IBDEI2EP ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40419,0)
 ;;=C43.9^^186^2076^314
 ;;^UTILITY(U,$J,358.3,40419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40419,1,3,0)
 ;;=3^Malig Melanoma,Skin,Unspec
 ;;^UTILITY(U,$J,358.3,40419,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,40419,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,40420,0)
 ;;=T85.49XA^^186^2076^341
 ;;^UTILITY(U,$J,358.3,40420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40420,1,3,0)
 ;;=3^Mech Complication,Oth,Breast Implant
 ;;^UTILITY(U,$J,358.3,40420,1,4,0)
 ;;=4^T85.49XA
 ;;^UTILITY(U,$J,358.3,40420,2)
 ;;=^5055574
 ;;^UTILITY(U,$J,358.3,40421,0)
 ;;=L76.22^^186^2076^362
 ;;^UTILITY(U,$J,358.3,40421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40421,1,3,0)
 ;;=3^Postprocedural Hemorr/Hematoma of Skin,Following Procedure
 ;;^UTILITY(U,$J,358.3,40421,1,4,0)
 ;;=4^L76.22
 ;;^UTILITY(U,$J,358.3,40421,2)
 ;;=^5009307
 ;;^UTILITY(U,$J,358.3,40422,0)
 ;;=M65.4^^186^2076^368
 ;;^UTILITY(U,$J,358.3,40422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40422,1,3,0)
 ;;=3^RAdial Styloid Tenosynovitis (de Quervain)
 ;;^UTILITY(U,$J,358.3,40422,1,4,0)
 ;;=4^M65.4
 ;;^UTILITY(U,$J,358.3,40422,2)
 ;;=^5012792
 ;;^UTILITY(U,$J,358.3,40423,0)
 ;;=C44.521^^186^2076^372
 ;;^UTILITY(U,$J,358.3,40423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40423,1,3,0)
 ;;=3^SCC Skin Breast
 ;;^UTILITY(U,$J,358.3,40423,1,4,0)
 ;;=4^C44.521
 ;;^UTILITY(U,$J,358.3,40423,2)
 ;;=^5001058
 ;;^UTILITY(U,$J,358.3,40424,0)
 ;;=C44.321^^186^2076^375
 ;;^UTILITY(U,$J,358.3,40424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40424,1,3,0)
 ;;=3^SCC Skin Nose
 ;;^UTILITY(U,$J,358.3,40424,1,4,0)
 ;;=4^C44.321
 ;;^UTILITY(U,$J,358.3,40424,2)
 ;;=^5001047
 ;;^UTILITY(U,$J,358.3,40425,0)
 ;;=C44.329^^186^2076^376
 ;;^UTILITY(U,$J,358.3,40425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40425,1,3,0)
 ;;=3^SCC Skin Oth Parts of Face
 ;;^UTILITY(U,$J,358.3,40425,1,4,0)
 ;;=4^C44.329
 ;;^UTILITY(U,$J,358.3,40425,2)
 ;;=^5001048
 ;;^UTILITY(U,$J,358.3,40426,0)
 ;;=C44.529^^186^2076^380
 ;;^UTILITY(U,$J,358.3,40426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40426,1,3,0)
 ;;=3^SCC Skin Trunk
 ;;^UTILITY(U,$J,358.3,40426,1,4,0)
 ;;=4^C44.529
 ;;^UTILITY(U,$J,358.3,40426,2)
 ;;=^5001059
 ;;^UTILITY(U,$J,358.3,40427,0)
 ;;=T86.821^^186^2076^384
 ;;^UTILITY(U,$J,358.3,40427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40427,1,3,0)
 ;;=3^Skin Graft Failure
 ;;^UTILITY(U,$J,358.3,40427,1,4,0)
 ;;=4^T86.821
 ;;^UTILITY(U,$J,358.3,40427,2)
 ;;=^5055735
 ;;^UTILITY(U,$J,358.3,40428,0)
 ;;=T86.822^^186^2076^385
 ;;^UTILITY(U,$J,358.3,40428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40428,1,3,0)
 ;;=3^Skin Graft Infection
 ;;^UTILITY(U,$J,358.3,40428,1,4,0)
 ;;=4^T86.822
 ;;^UTILITY(U,$J,358.3,40428,2)
 ;;=^5055736
 ;;^UTILITY(U,$J,358.3,40429,0)
 ;;=T86.820^^186^2076^386
 ;;^UTILITY(U,$J,358.3,40429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40429,1,3,0)
 ;;=3^Skin Graft Rejection
 ;;^UTILITY(U,$J,358.3,40429,1,4,0)
 ;;=4^T86.820
 ;;^UTILITY(U,$J,358.3,40429,2)
 ;;=^5055734
 ;;^UTILITY(U,$J,358.3,40430,0)
 ;;=11719^^187^2077^4^^^^1
 ;;^UTILITY(U,$J,358.3,40430,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40430,1,2,0)
 ;;=2^Trimming Nondystrophic Nails, any number
 ;;^UTILITY(U,$J,358.3,40430,1,3,0)
 ;;=3^11719
 ;;^UTILITY(U,$J,358.3,40431,0)
 ;;=G0127^^187^2077^3^^^^1
 ;;^UTILITY(U,$J,358.3,40431,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,40431,1,2,0)
 ;;=2^Trimming Dystrophic Nails, any number
 ;;^UTILITY(U,$J,358.3,40431,1,3,0)
 ;;=3^G0127
 ;;^UTILITY(U,$J,358.3,40432,0)
 ;;=11720^^187^2077^1^^^^1
 ;;^UTILITY(U,$J,358.3,40432,1,0)
 ;;=^358.31IA^3^2
